ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $23,606,000 | +6.1% | 179,446 | +4.0% | 0.03% | 0.0% |
| Q1 2021 | $22,242,000 | -15.4% | 172,584 | +9.5% | 0.03% | -17.1% |
| Q4 2020 | $26,291,000 | +36.3% | 157,636 | +26.1% | 0.04% | +25.0% |
| Q3 2020 | $19,292,000 | +3.2% | 125,010 | -1.1% | 0.03% | -6.7% |
| Q2 2020 | $18,693,000 | +42.4% | 126,390 | +8.4% | 0.03% | +11.1% |
| Q1 2020 | $13,129,000 | -19.9% | 116,595 | -1.1% | 0.03% | -3.6% |
| Q4 2019 | $16,399,000 | +34.2% | 117,881 | -7.1% | 0.03% | +16.7% |
| Q3 2019 | $12,220,000 | +4.9% | 126,867 | +25.4% | 0.02% | +9.1% |
| Q2 2019 | $11,653,000 | -7.8% | 101,203 | -5.7% | 0.02% | -12.0% |
| Q1 2019 | $12,635,000 | +87.2% | 107,344 | -0.3% | 0.02% | +56.2% |
| Q4 2018 | $6,748,000 | +8.1% | 107,703 | +22.3% | 0.02% | +33.3% |
| Q3 2018 | $6,240,000 | – | 88,055 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |